{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:27:41Z","timestamp":1790803661698,"version":"4.1.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:p>Focal therapy is a modern alternative to selectively treat a specific part of the prostate harboring clinically significant disease while preserving the rest of the gland. The aim of this therapeutic approach is to retain the oncological benefit of active treatment and to minimize the side-effects of common radical treatments. The oncological effectiveness of focal therapy is yet to be proven in long-term robust trials. In contrast, the toxicity profile is well-established in randomized controlled trials and multiple robust prospective cohort studies. This narrative review summarizes the relevant evidence on complications and their management after focal therapy. When compared to whole gland treatments, focal therapy provides a substantial benefit in terms of adverse events reduction and preservation of genito-urinary function. The most common complications occur in the peri-operative period. Urinary tract infection and acute urinary retention can occur in up to 17% of patients, while dysuria and haematuria are more common. Urinary incontinence following focal therapy is very rare (0\u20135%), and the vast majority of patients recover in few weeks. Erectile dysfunction can occur after focal therapy in 0\u201346%: the baseline function and the ablation template are the most important factors predicting post-operative erectile dysfunction. Focal therapy in the salvage setting after external beam radiotherapy has a significantly higher rate of complications. Up to one man in 10 will present a severe complication.<\/jats:p>","DOI":"10.3389\/fsurg.2021.696242","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T05:18:11Z","timestamp":1626067091000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Focal Therapy for Prostate Cancer: Complications and Their Treatment"],"prefix":"10.3389","volume":"8","author":[{"given":"Arnas","family":"Rakauskas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Heidegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeru","family":"Kasivisvanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kretschmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Zattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Preisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Tilki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Tsaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ceci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Fankhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"key":"B1","unstructured":"Available online at:2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJMoa1209978","article-title":"Long-term functional outcomes after treatment for localized prostate cancer","volume":"368","author":"Resnick","year":"2013","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.21037\/tau.2020.02.15","article-title":"Radical prostatectomy versus brachytherapy for clinically localized prostate cancer on oncological and functional outcomes: a meta-analysis","volume":"9","author":"Zhang","year":"2020","journal-title":"Transl Androl Urol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/pcan.2017.8","article-title":"Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project","volume":"20","author":"Tay","year":"2017","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/MOU.0000000000000041","article-title":"Imaging modalities in focal therapy: patient selection, treatment guidance, and follow-up","volume":"24","author":"Muller","year":"2014","journal-title":"Curr Opin Urol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2217\/fon-2016-0229","article-title":"Focal therapy as primary treatment for localized prostate cancer: definition, needs and future","volume":"13","author":"Ouzzane","year":"2017","journal-title":"Future Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.eururo.2014.09.018","article-title":"Focal therapy: patients, interventions, and outcomes\u2013a report from a consensus meeting","volume":"67","author":"Donaldson","year":"2015","journal-title":"Eur Urol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/bjc.2017.57","article-title":"The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy","volume":"116","author":"Simmons","year":"2017","journal-title":"Br J Cancer."},{"key":"B12","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.eururo.2013.05.048","article-title":"The role of focal therapy in the management of localised prostate cancer: a systematic review","volume":"66","author":"Valerio","year":"2014","journal-title":"Eur Urol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.euo.2020.12.008","article-title":"A systematic review of focal ablative therapy for clinically localised prostate cancer in comparison with standard management options: limitations of the available evidence and recommendations for clinical practice and further research","volume":"4","author":"Bates","year":"2021","journal-title":"Eur Urol Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.eururo.2015.10.030","article-title":"The effects of focal therapy for prostate cancer on sexual function: a combined analysis of three prospective trials","volume":"69","author":"Yap","year":"2016","journal-title":"Eur Urol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.eururo.2015.12.015","article-title":"Focal therapy for prostate cancer: an \u201c\u00c0 la Carte\u201d approach","volume":"69","author":"Sivaraman","year":"2016","journal-title":"Eur Urol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/JU.0000000000001327","article-title":"Impact of focal versus whole gland ablation for prostate cancer on sexual function and urinary continence","volume":"205","author":"Borges","year":"2021","journal-title":"J Urol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.juro.2015.02.080","article-title":"Image guided focal therapy of magnetic resonance imaging visible prostate cancer: defining a 3-dimensional treatment margin based on magnetic resonance imaging-histology co-registration analysis","volume":"194","author":"Le Nobin","year":"2015","journal-title":"J Urol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/JU.0000000000001389","article-title":"Predicting pathological tumor size in prostate cancer based on multiparametric prostate magnetic resonance imaging and preoperative findings","volume":"205","author":"Pooli","year":"2021","journal-title":"J Urol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.juro.2016.07.084","article-title":"Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology","volume":"197","author":"Priester","year":"2017","journal-title":"J Urol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.eururo.2020.05.018","article-title":"Standardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer: an international multidisciplinary consensus","volume":"78","author":"Lebastchi","year":"2020","journal-title":"Eur Urol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/bju.14088","article-title":"Has tailored, tissue-selective tumour ablation in men with prostate cancer come of age?","volume":"121","author":"Emberton","year":"2018","journal-title":"BJU Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.urolonc.2019.09.001","article-title":"Prospective multicentre study using high intensity focused ultrasound (HIFU) for the focal treatment of prostate cancer: safety outcomes and complications","volume":"38","author":"Schmid","year":"2020","journal-title":"Urol Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.eururo.2015.01.030","article-title":"Focal ablation targeted to the index lesion in multifocal localised prostate cancer: a prospective development study","volume":"68","author":"Ahmed","year":"2015","journal-title":"Eur Urol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1089\/end.2014.0670","article-title":"Management of catheter-related bladder discomfort in patients who underwent elective surgery","volume":"29","author":"Bai","year":"2015","journal-title":"J Endourol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1470-2045(16)30661-1","article-title":"Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial","volume":"18","author":"Azzouzi","year":"2017","journal-title":"Lancet Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta22520","article-title":"Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT","volume":"22","author":"Hamdy","year":"2018","journal-title":"Health Technol Assess."},{"key":"B27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.eururo.2018.06.006","article-title":"A Multicentre study of 5-year outcomes following focal therapy in treating clinically significant non-metastatic prostate cancer","volume":"74","author":"Guillaumier","year":"2018","journal-title":"Eur Urol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.eururo.2018.12.030","article-title":"Early-medium-term outcomes of primary focal cryotherapy to treat non-metastatic clinically significant prostate cancer from a prospective multicentre registry","volume":"76","author":"Shah","year":"2019","journal-title":"Eur Urol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1159\/000507123","article-title":"Prospective feasibility study of single-shot antibiotic prophylaxis in transrectal focal ablation of prostate cancer","volume":"104","author":"Westhoff","year":"2020","journal-title":"UIN."},{"key":"B30","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S1470-2045(12)70121-3","article-title":"Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study","volume":"13","author":"Ahmed","year":"2012","journal-title":"Lancet Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1089\/end.2018.0809","article-title":"Comprehensive evaluation of focal therapy complications in prostate cancer: a standardized methodology","volume":"33","author":"Bakavicius","year":"2019","journal-title":"J Endourol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.urolonc.2017.12.002","article-title":"A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: A systematic review","volume":"36","author":"Faure Walker","year":"2018","journal-title":"Urol Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/medsci7120109","article-title":"Ejaculatory and Orgasmic Dysfunction Following Prostate Cancer Therapy: Clinical Management","volume":"7","author":"Green","year":"2019","journal-title":"Med Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e045500","DOI":"10.1136\/bmjopen-2020-045500","article-title":"Detailing sexual outcomes after treatment of localised prostate cancer with focal therapy using various energy sources: protocol for a mixed-methods study","volume":"10","author":"Fiard","year":"2020","journal-title":"BMJ Open."},{"key":"B35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.prnil.2019.12.002","article-title":"Survival and quality of life outcomes of high-intensity focused ultrasound treatment of localized prostate cancer","volume":"8","author":"Royce","year":"2020","journal-title":"Prostate Int."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.21037\/tau.2019.08.21","article-title":"A systematic review of salvage focal therapies for localised non-metastatic radiorecurrent prostate cancer","volume":"9","author":"Khoo","year":"2020","journal-title":"Transl Androl Urol."}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2021.696242\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T05:18:13Z","timestamp":1626067093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2021.696242\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":36,"alternative-id":["10.3389\/fsurg.2021.696242"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2021.696242","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,12]]},"article-number":"696242"}}